137 related articles for article (PubMed ID: 9183082)
1. Viral transmission by blood products: a perspective of events covered by the recent tribunal of enquiry into the Irish Blood Transfusion Board.
Yap PL
Ir Med J; 1997; 90(3):84, 86, 88. PubMed ID: 9183082
[TBL] [Abstract][Full Text] [Related]
2. The viral safety of intravenous immune globulin.
Yap PL
Clin Exp Immunol; 1996 May; 104 Suppl 1():35-42. PubMed ID: 8625542
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus associated with Irish anti-D immunoglobulin.
Commun Dis Rep CDR Wkly; 1994 Mar; 4(9):39. PubMed ID: 7513236
[No Abstract] [Full Text] [Related]
4. Estimated risk of transmission of hepatitis C virus by blood transfusion.
Koerner K; Cardoso M; Dengler T; Kerowgan M; Kubanek B
Vox Sang; 1998; 74(4):213-6. PubMed ID: 9691400
[TBL] [Abstract][Full Text] [Related]
5. A second outbreak of hepatitis C virus infection from anti-D immunoglobulin in Ireland.
Smith DB; Lawlor E; Power J; O'Riordan J; McAllister J; Lycett C; Davidson F; Pathirana S; Garson JA; Tedder RS; Yap PL; Simmonds P
Vox Sang; 1999; 76(3):175-80. PubMed ID: 10341334
[TBL] [Abstract][Full Text] [Related]
6. Results of a hepatitis C general transfusion lookback program for patients who received blood products before July 1992.
Williams JL; Cagle HH; Christensen CJ; Fox-Leyva LK; McMahon BJ
Transfusion; 2005 Jun; 45(6):1020-6. PubMed ID: 15935002
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus and intravenous anti-D immunoglobulin.
Commun Dis Rep CDR Wkly; 1995 Jun; 5(24):111, 114. PubMed ID: 7542122
[No Abstract] [Full Text] [Related]
8. Hepatitis C viraemia in recipients of Irish intravenous anti-D immunoglobulin.
Power JP; Lawlor E; Davidson F; Yap PL; Kenny-Walsh E; Whelton MJ; Walsh TJ
Lancet; 1994 Oct; 344(8930):1166-7. PubMed ID: 7934528
[No Abstract] [Full Text] [Related]
9. Legal, financial, and public health consequences of transfusion-transmitted hepatitis C virus in persons with haemophilia.
Angelotta C; McKoy JM; Fisher MJ; Buffie CG; Barfi K; Ramsey G; Frohlich L; Bennett CL
Vox Sang; 2007 Aug; 93(2):159-65. PubMed ID: 17683360
[TBL] [Abstract][Full Text] [Related]
10. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
[TBL] [Abstract][Full Text] [Related]
11. Viral load change and sequential evolution of entire hepatitis C virus genome in Irish recipients of single source-contaminated anti-D immunoglobulin*.
Itakura J; Nagayama K; Enomoto N; Hamano K; Sakamoto N; Fanning LJ; Kenny-Walsh E; Shanahan F; Watanabe M
J Viral Hepat; 2005 Nov; 12(6):594-603. PubMed ID: 16255760
[TBL] [Abstract][Full Text] [Related]
12. Acute renal failure after intravenous anti-D immune globulin in an adult with immune thrombocytopenic purpura.
Chun NS; Savani B; Seder RH; Taplin ME
Am J Hematol; 2003 Dec; 74(4):276-9. PubMed ID: 14635210
[TBL] [Abstract][Full Text] [Related]
13. Transmission rates of hepatitis C virus by different batches of a contaminated anti-D immunoglobulin preparation.
Lawlor E; Power J; Garson J; Yap P; Davidson F; Columb G; Smith D; Pomeroy L; O'Riordan J; Simmonds P; Tedder R
Vox Sang; 1999; 76(3):138-43. PubMed ID: 10341327
[TBL] [Abstract][Full Text] [Related]
14. Characterization of HCV strains in an oncohematological pediatric department reveals little horizontal transmission but multiple introductions by un-screened blood products in the past.
Stikleryte A; Griskeviciene J; Magnius LO; Zagminas K; Norder H; Ambrozaitis A
J Med Virol; 2006 Nov; 78(11):1411-22. PubMed ID: 16998896
[TBL] [Abstract][Full Text] [Related]
15. Intravenous immunoglobulin and hepatitis C virus: an overview of transmission episodes with emphasis on manufacturing data.
Yap PL
Clin Ther; 1996; 18 Suppl B():43-58. PubMed ID: 8930441
[TBL] [Abstract][Full Text] [Related]
16. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
[TBL] [Abstract][Full Text] [Related]
17. Transmission of hepatitis C virus by blood transfusions and other medical procedures: a global review.
Prati D
J Hepatol; 2006 Oct; 45(4):607-16. PubMed ID: 16901579
[TBL] [Abstract][Full Text] [Related]
18. Transmission of viral infections through intravenous immune globulin.
Schiff RI
N Engl J Med; 1994 Dec; 331(24):1649-50. PubMed ID: 7969346
[No Abstract] [Full Text] [Related]
19. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus.
Seed CR; Kiely P; Keller AJ
Intern Med J; 2005 Oct; 35(10):592-8. PubMed ID: 16207258
[TBL] [Abstract][Full Text] [Related]
20. Low rate of HCV transmission from women infected with contaminated anti-D immunoglobulin to their family contacts.
Sachithanandan S; Fielding JF
Ital J Gastroenterol Hepatol; 1997 Feb; 29(1):47-50. PubMed ID: 9265578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
